NCT05887934
Bone-Lead Level Associations With Brain and Mental Health
Enrolling by Invitation
Not specifiedAges 18–70ObservationalMedical University of South CarolinaInvestigator-initiated
~500 participants
Updated 2025-10-14 on ClinicalTrials.gov
What's tested:X-Ray Fluorescence Analyzer
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Neuropsychiatric Diagnoses
Measured over Baseline
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesSouth Carolina1
Study leadership
- Dean Kilpatrick, Ph.D. · PRINCIPAL_INVESTIGATOR · Medical University of South Carolina
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age 18-70
Ability to read, write, and comprehend English
Capacity to consent
Consented for recontact, when applicable
Negative pregnancy test
Exclusion
Pregnant
Current schizophrenia or psychotic disorder
Inability or unwillingness of subject to give informed consent
What this trial measures
- Neuropsychiatric DiagnosesBaseline
Count of participants varying neuropsychiatric disorders assessed by the Diagnostic Interview for Anxiety, Mood, and OCD and related Neuropsychiatric Disorders (DIAMOND)
- Cognitive FunctionBaseline
Measurement of cognitive function as assessed by the Trail Making Test (TMT) as a way to assess central executive functioning.